Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Intelligence

Set Alert for Market Intelligence

Multiple Molecules See UK Prices Double In March

Etoricoxib, letrozole and trimethoprim experienced triple-digit rises in their average UK trade prices in March, according to the latest figures from WaveData.

Market Intelligence Pricing Strategies

French Market Survives On New Generics

After a year that French industry association Gemme says has demonstrated the importance of a sustainable generics sector, the market continued to grow purely due to the contribution made by newly genericized molecules.

Market Intelligence France

Still More To Be Done On European Biosimilars

Off-patent industry association Medicines for Europe has released a Biosimilar Market Review report that examines availability, pricing systems, retail markets, hospital tendering, reimbursement systems, healthcare practitioner-related policies, information and education around biosimilars in 26 European countries, concluding that “while progress has been made, it is clear much more can be done.” 

Europe Biosimilars

Generics Coverage Worsens Under Medicare Plans In 2021

Based on the latest AAM-sponsored study by Avalere Health, the US off-patent industry association has asked policymakers to initiate Medicare Part D reforms. Generic prescription drugs are only placed on generic tiers 45% of the time in 2021, a significant decrease from the 64% seen in 2016.

United States BioPharmaceutical

Olmesartan Prices Treble In UK

Average UK trade prices of olmesartan as much as trebled across multiple presentations in the second month of 2021. However, this was not the only triple-digit price rise seen during February, WaveData reveals.

Market Intelligence Pricing Strategies

Ramipril And Loperamide Shoot Up In Early 2021

Both ramipril and loperamide saw average UK trade prices that more than doubled in January 2021.

Market Intelligence Pricing Strategies
See All
UsernamePublicRestriction

Register